Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-25T00:59:27
publisher: Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment
type: Document
label: RDF description of Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment - http://irises.unisr.it/resource/item/225818

Generically Dependent Continuant
type: Class

Article
type: Class

Inglese
type: Language

Information Content Entity
type: Class

387569731
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment

387569732
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment

Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment
type: Generically Dependent Continuant
language: Inglese
type: Information Content Entity
type: Document
type: Thing
type: Article
related by: 387569732
type: Entity
type: Continuant
most specific type: Academic Article
type: Academic Article
related by: 387569731